论文信息 - RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug. - 字舞流文

RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug.

F. Buchholz | Mirko Theis | G. Ehninger | A. Dahl | Maciej Paszkowski-Rogacz | U. Platzbecker | M. Wermke | M. Bornhäuser | M. von Bonin | S. Thieme | S. Brenner | A. Camgoz